Efficacy of a synuclein and tau fibril targeting drug in vivo
While higher or longer dosing might disaggregate and clear insoluble fibrils, this initial study suggests oral dosing produces pleiotropic CNS activity against both aSyn and tau pre-fibrillar oligomers implicated in the neurotoxicity, seeding and spreading of two major proteinopathies.
Authors
- Ke Hou (ORCID: https://orcid.org/0000-0003-3869-2076)
- Mychica Jones
- David Eisenberg (ORCID: https://orcid.org/0000-0003-2432-5419)
- Sally A. Frautschy (ORCID: https://orcid.org/0000-0003-0194-0363)
- Cansheng Zhu
- Gregory M. Cole
- Kapil Manglani
- Alex Bombino
Institutions
- West Los Angeles College (US)
- United States Department of Veterans Affairs (US)
- Howard Hughes Medical Institute (US)
- University of California, Los Angeles (US)
- UCLA Health (US)
- Foundation for Psychocultural Research (US)
- Geriatric Research Education and Clinical Center (US)
- VA Greater Los Angeles Healthcare System (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_106249
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00